- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06219577
Subjective and Objective Performance of Systane Complete Multi-Dose PF Versus Walgreen's Lubricant Balance
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: Leslie Shan
- Phone Number: 858-530-2800
- Email: lshanod@gmail.com
Study Locations
-
-
California
-
San Diego, California, United States, 92131
- Scripps Poway Eyecare & Optometry
-
Principal Investigator:
- Jay Mashouf, OD
-
Contact:
- Leslie Shan
- Phone Number: 858-530-2800
- Email: lshanod@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Subjects are eligible for the study if they meet the following criteria:
Note: Ocular criteria must be met in both eyes.
- Subjects who currently have mild to moderate symptoms of dry eye as defined by a screening SANDE score of 20-55 inclusive (equivalent to OSDI score of 12 -32).2
- Subjects between the ages of 18-65.
- Subjects willing to comply with the prescribed regimen and schedule of eye drops.
- Subjects willing to attend all study visits.
- Subjects willing to discontinue any current artificial tear use 24 hours prior to the baseline study visit.
Exclusion Criteria:
If any of the following exclusion criteria are applicable to the subject or either eye, the subject should not be enrolled in the study.
- Ocular anterior segment infection, inflammation, abnormality, or active disease.
- History of herpetic keratitis or ocular surgery.
- Recent (within 1 year) thermal meibomian gland expression procedure including Lipiflow, iLux, or TearCare.
- Recent (within 1 year) blepharitis debridement procedure including BlephEx.
- Screening SANDE score > 55 (equivalent to OSDI score of >32).2 This is indicative of a severe dry eye.
- Screening SANDE score < 20 (equivalent to OSDI score of <12).2 This is indicative of a clinically normal eye.
- Screening non-invasive TBUT < 2 seconds, or > 10 seconds.3
- Screening NaFl score < 3 (clinically normal eye) or > 10 (severe dry eye).4
- Pregnant or lactating.
- Current use of contact lenses.
- Any change in eye drop regimen, whether OTC or RX in the last 90 days.
The principal investigator reserves the right to declare a patient ineligible or non-evaluable based on medical evidence that indicates they are unsuitable for the trial.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Systane Complete Multi-Dose PF
|
Eyedrop
|
Other: Walgreen's Lubricant Balance
|
Eyedrop
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SANDE Questionnaire
Time Frame: 2 weeks
|
Subjects are asked to place an 'X' on the line to indicate the frequency and severity of their dry eye symptoms.
Higher scores on the questionnaire indicate more frequent or severe dry eye symptoms.
|
2 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Corneal and conjunctival staining
Time Frame: 2 weeks
|
Baseline corneal and conjunctival staining with sodium fluorescein and Wratten filter assessed OU using the Academy of Ophthalmology 5 quadrant scheme.
Each quadrant will be graded (0-3) giving a total score of 0-15 per eye.
|
2 weeks
|
Non-invasive tear breakup time
Time Frame: 2 weeks
|
2 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Jay Mashouf, OD, Scripps Poway Eyecare & Optometry
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- JM-23-02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dry Eye
-
Gordon Schanzlin New VisionCompletedDry Eye | Dry Eye Disease | Evaporative Dry Eye | Kerato Conjunctivitis Sicca | Evaporative Dry Eye Disease | Dry Eye, EvaporativeUnited States
-
Kao (Taiwan) CorporationChang Gung Memorial HospitalCompletedEye Fatigue | Dry Eye SymptomTaiwan
-
Alcon ResearchCompletedVisual Performance | Dry Eye Symptoms
-
Alcon ResearchCompletedModerate to Severe Dry Eye
-
Singapore National Eye CentreCompleted
-
Senju Pharmaceutical Co., Ltd.CompletedDry Eye Syndrome | Dry Eye DiseaseUnited States
-
AllerganCompletedDry Eye Syndrome | Dry Eye DiseaseUnited States
-
Bausch & Lomb IncorporatedCompletedDry Eye Disease (DED)United States
-
Centre for Contact Lens ResearchCoopervision, Inc.CompletedContact Lens Related Dry EyeCanada
-
Singapore National Eye CentreCompleted
Clinical Trials on Systane Complete Multi-Dose PF
-
Horus PharmaNot yet recruitingDry Eye | Meibomian Gland Dysfunction
-
Ohio State UniversityAlcon ResearchCompletedEye Diseases | Dry Eye Syndromes | Keratoconjunctivitis Sicca | Lacrimal Apparatus Diseases | Keratoconjunctivitis | Keratitis | Corneal Disease | Ophthalmic SolutionUnited States
-
University of California, BerkeleyAlcon ResearchCompleted
-
Weill Medical College of Cornell UniversityWithdrawn
-
University of Alabama at BirminghamAlcon Research; Southern College of Optometry; Lindenhurst Eye Physicians & Surgeons...CompletedDry Eye | Contact Lens DiscomfortUnited States
-
University of WaterlooCompletedEvaporative Dry EyeCanada
-
PfizerCompleted
-
University of Alabama at BirminghamAlcon ResearchCompleted
-
University of Alabama at BirminghamAlcon ResearchCompletedDry Eye | Contact Lens ComplicationUnited States